Bioavailability of intravenous versus subcutaneous administration of the dual GC-A and GC-B designer natriuretic peptide cenderitide in healthy canines

Antzeko izenburuak

• The novel dual GC-A and GC-B designer natriuretic peptide, cenderitide (CD-NP), enhances the renal actions of furosemide in a model of severe heart failure
  nork: Costello-Boerrigter, Lisa C, et al.
  Argitaratua: (2011)
• Renal and Anti-Aldosterone Actions of Vasopressin-2 Receptor Antagonism and B-Type Natriuretic Peptide in Experimental Heart Failure
  nork: Costello-Boerrigter, Lisa C., et al.
  Argitaratua: (2010)
• Natriuretic Peptides in the Diagnosis and Management of Chronic Heart Failure
  nork: Boerrigter, Guido, et al.
  Argitaratua: (2009)
• B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity
  nork: Boerrigter, Guido, et al.
  Argitaratua: (2009)
• Natriuretic Peptide Based Therapeutics For Heart Failure: Cenderitide: A Novel First-In-Class Designer Natriuretic Peptide
  nork: Ichiki, Tomoko, et al.
  Argitaratua: (2018)